Literature DB >> 21554855

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).

D Price1, S Musgrave, E Wilson, E Sims, L Shepstone, A Blyth, J Murdoch, M Mugford, E Juniper, J Ayres, S Wolfe, D Freeman, A Lipp, R Gilbert, I Harvey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21554855     DOI： 10.3310/hta15210

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  6 in total

1.  Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.

Authors:  Edward C F Wilson; David Price; Stanley D Musgrave; Erika J Sims; Lee Shepstone; Jamie Murdoch; H Miranda Mugford; Annie Blyth; Elizabeth F Juniper; Jon G Ayres; Stephanie Wolfe; Daryl Freeman; Richard F T Gilbert; Elizabeth V Hillyer; Ian Harvey
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.

Authors:  Edward C F Wilson; Erika J Sims; Stanley D Musgrave; Lee Shepstone; Annie Blyth; Jamie Murdoch; H Miranda Mugford; Elizabeth F Juniper; Jon G Ayres; Stephanie Wolfe; Daryl Freeman; Richard F T Gilbert; Ian Harvey; Elizabeth V Hillyer; David Price
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review.

Authors:  Carlos E Rodriguez-Martinez; Monica P Sossa-Briceño; Jose A Castro-Rodriguez
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

4.  Scientific respiratory symposium, paris june 2010.

Authors:  Gavin Dalglish; Graham Priestley
Journal:  J Asthma Allergy       Date:  2011-06-29

5.  Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study.

Authors:  Claire Snowdon; Diana R Elbourne; Jo Garcia; Marion K Campbell; Vikki A Entwistle; David Francis; Adrian M Grant; Rosemary C Knight; Alison M McDonald; Ian Roberts
Journal:  Trials       Date:  2006-12-21       Impact factor: 2.279

6.  Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler.

Authors:  David B Price; Gene Colice; Elliot Israel; Nicolas Roche; Dirkje S Postma; Theresa W Guilbert; Willem M C van Aalderen; Jonathan Grigg; Elizabeth V Hillyer; Victoria Thomas; Richard J Martin
Journal:  ERJ Open Res       Date:  2016-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.